Form 4: MasTec Director Amends Forward Sale Contract Terms

MasTec Director Jorge Mas's entity amended a prepaid variable forward sale contract, adjusting pledged shares and price thresholds.

Summary

• Jorge Mas Holdings I, LLC, an entity controlled by MasTec Director Jorge Mas, entered into a third amendment to a prepaid variable forward sale contract with an unaffiliated third-party buyer.
• The amendment, dated August 18, 2025, adjusted the Floor Price and Cap Price for each Tranche 2 Component of the contract.
• The number of MasTec, Inc. common shares pledged to secure obligations under the contract was reduced from 1,176,933 to 1,099,335 shares.
• The contract provides for settlement, at JM Holdings I's option, in cash or shares of MasTec, Inc. common stock.
• The pledged shares are divided into two tranches, each with 15 components, with specific price thresholds: Tranche 1 Floor Price of $97.3535, Tranche 1 Cap Price of $127.6413, Tranche 2 Floor Price of $157.3441, and Tranche 2 Cap Price of $243.0093.
• The number of shares or cash to be delivered upon settlement is determined by MasTec's stock price relative to these Floor and Cap Prices on the respective valuation dates.
• Jorge Mas retains beneficial ownership and voting rights of all shares of MasTec common stock subject to the Amended Agreement.

Sentiment

Score: 5

Explanation: Neutral. This is a routine amendment to a pre-existing financial instrument for a director, not indicative of significant positive or negative operational performance for the company. The retention of voting rights is a minor positive, while the reduction in pledged shares is a minor negative, balancing out to neutral.

Positives

• The reporting person, Jorge Mas, retains beneficial ownership and voting rights of all shares subject to the Amended Agreement, indicating continued alignment with shareholder interests.
• The amendment provides flexibility for settlement in cash or shares, allowing JM Holdings I to optimize its position based on future market conditions.

Negatives

• The number of shares pledged under the forward sale contract was reduced from 1,176,933 to 1,099,335, which represents a decrease in the underlying collateral for the contract.

Risks

• Potential obligation to sell a significant number of MasTec common shares (up to 1,099,335 shares) depending on the stock's performance relative to the defined Floor and Cap Prices.
• Exposure to market price fluctuations of MasTec common stock, which will determine the number of shares or cash to be delivered upon settlement of the contract components.

Future Outlook

The forward sale contract components are exercisable and expire between August 17, 2026, and September 3, 2027, indicating the future period over which the potential share delivery or cash settlement will occur.

Management Comments

• The reporting person currently retains beneficial ownership of all shares of MasTec common stock that are subject to the Amended Agreement and rights related thereto, including all voting rights.

Industry Context

na

Related Party Transactions

• The transaction involves Jorge Mas, a Director of MasTec, Inc., and JM Holdings I, LLC, an entity he controls, making it a related party transaction concerning the company's common stock.

Stakeholder Impact

• Shareholders: The potential future sale of up to 1,099,335 shares could introduce selling pressure on MasTec's stock, though the timing and amount are variable. The retention of voting rights by Jorge Mas ensures his continued influence.

Next Steps

• Settlement of the forward sale contract components will occur between August 17, 2026, and September 3, 2027, based on MasTec's stock price at the respective valuation dates.

Key Dates

Recommendation

This Form 4 filing details an amendment to a director's pre-existing forward sale contract, which is a routine disclosure for an insider transaction. It does not provide new information about MasTec's operational performance, financial health, or strategic direction that would warrant a change in investment thesis. The transaction itself is a re-adjustment of a personal financial instrument, with the director retaining voting rights, suggesting continued alignment. Therefore, a 'hold' recommendation is appropriate as there's no new fundamental information to alter an existing investment stance.

Keywords

MasTec, MTZ, Jorge Mas, SEC Form 4, Forward Sale Contract, Beneficial Ownership, Director Transaction, Equity Derivatives, Share Pledge